Stay updated on REGN3500 Efficacy/Safety/PK in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the REGN3500 Efficacy/Safety/PK in Atopic Dermatitis Clinical Trial page.

Latest updates to the REGN3500 Efficacy/Safety/PK in Atopic Dermatitis Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedA new Locations section with listed study sites in the United States, Canada, and Hungary (including Bekes County and Hajdú-Bihar) was added, and the page revision tag was updated to v3.3.3.SummaryDifference2%

- Check17 days agoNo Change Detected
- Check32 days agoChange DetectedRevision updated from v3.2.0 to v3.3.2. No visible changes to the page content.SummaryDifference0.0%

- Check39 days agoChange DetectedThe government funding/status notice banner was removed from the page. No new content was added, and the study details remain unchanged.SummaryDifference0.2%

- Check61 days agoChange DetectedNo significant additions or deletions are visible in the two screenshots; the page content and layout appear unchanged.SummaryDifference0.2%

- Check82 days agoChange DetectedUpdate includes a status notice about government funding and operating status plus a new version tag (v3.2.0); the old version tag (v3.1.0) was removed.SummaryDifference2%

- Check90 days agoChange Detected- Updated the page version from v3.0.2 to v3.1.0. Minor overall impact, mainly reflects a version increment.SummaryDifference0.0%

Stay in the know with updates to REGN3500 Efficacy/Safety/PK in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the REGN3500 Efficacy/Safety/PK in Atopic Dermatitis Clinical Trial page.